Biographical Sketch
Brian Mandell, MD, PhD, is board-certified in internal medicine and rheumatology. He is Director of Scholarly Activities of the Internal Medicine Residency Program at Cleveland Clinic, and serves on the Clinic's Board of Governors, the Graduate Medical Education Council, Continuing Health Sciences Education Committee, and Education Governing Group.
Dr. Mandell is also Editor-in-Chief, Cleveland Clinic Journal of Medicine.
Specialty Interests
Gout, multisystem involvement from autoimmune disease, myositis, systemic lupus, Vasculitis
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 7/30/2008, Dr.
Mandell has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Mandell receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Merck & Co. Inc. (Merck Manual)
Fiduciary Role. Dr. Mandell serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
Gout and Uric Acid Society
